Therapeutic areas

Oncology

Cancer incidence in Kenya has been increasing year on year, with the disease burden falling disproportionately on patients who reach diagnosis late and on the small number of treatment centres equipped to manage them. The consistent availability of registered cytotoxic, hormonal and supportive-care agents directly affects whether a planned treatment cycle proceeds on time.

Daren registers and supplies oncology medicines to public and private hospitals in Kenya, including day-care oncology units.

Nephrology

Patients on chronic haemodialysis require recurring access to erythropoiesis-stimulating agents, parenteral iron, anticoagulation for the dialysis circuit, and — for transplant recipients — long-term immunosuppression. Each interruption in supply translates directly into morbidity.

Daren supports nephrology services in Kenya by registering and distributing this core basket.

Biotherapy

Coagulation factors, intravenous immunoglobulins and human albumin sit in a separate part of the supply chain from small molecules — donor source, fractionation plant, cold-chain integrity and batch traceability matter as much as the active pharmaceutical ingredient itself.

Daren imports plasma-derived products only from manufacturers with established regulatory standing and chain-of-custody documentation.

Critical Care & Hospital

Operating theatres, intensive-care units and high-dependency wards rely on a narrow but indispensable set of injectables — neuromuscular blockers, sedation agents and selected critical-care medicines. Daren registers and supplies these to Kenyan hospital pharmacies.